Massen, G. M., Blamires, O. ., Grainger, M. ., Matta, M. ., Twumasi, R. M. G., Joshi, T. ., … Quint, J. K. (2024). UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications. Pragmat Obs Res, 15, 151–164. http://doi.org/10.2147/por.s469973
Copd
Hatam, S. ., Scully, S. T., Cook, S. ., Evans, H. T., Hume, A. ., Kallis, C. ., … Quint, J. K. (2024). A Harmonised Approach to Curating Research-Ready Datasets for Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD) in England, Wales and Scotland Using CPRD, SAIL Databank and DataLoch. Clin Epidemiol, 16, 235–247. http://doi.org/10.2147/clep.s437937
Whittaker, H. R., Torkpour, A. ., & Quint, J. . (2024). Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data. Respir Res, 25, 43. http://doi.org/10.1186/s12931-024-02672-x
Tse, G. ., Emmanuel, B. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., … Price, D. . (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565–2580. http://doi.org/10.2147/copd.s433326
Rothnie, K. J., Numbere, B. ., Gelwicks, S. ., Lu, Y. ., Sharma, R. ., Compton, C. ., … Quint, J. K. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673–2685. http://doi.org/10.2147/copd.s413947
Stone, P. W., Osen, M. ., Ellis, A. ., Coaker, R. ., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565–1574. http://doi.org/10.2147/copd.s411739
Wickramasinghe, B. ., Renzi, C. ., Barclay, M. ., Callister, M. E. J., Rafiq, M. ., & Lyratzopoulos, G. . (2023). Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data. Cancer Epidemiol, 86, 102429. http://doi.org/10.1016/j.canep.2023.102429
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Halpin, D. M. G., Rothnie, K. J., Banks, V. ., Czira, A. ., Compton, C. ., Wood, R. ., … Vogelmeier, C. F. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417–2429. http://doi.org/10.2147/copd.s370540
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480